Search research articles
Contact Us
Filters
Showing results (61-70 of 90) with videos related to
Page
of 9
Sort By:
Communications Biology
|
February 5, 2025
Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancer
Bengul Gokbayrak, Umut Berkay Altintas, Shreyas Lingadahalli, et al.
Cancer Research
|
September 2, 2020
Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non-Muscle-Invasive Bladder Cancer
Joaquim Bellmunt, Jaegil Kim, Brendan Reardon, et al.
Nature Medicine
|
April 26, 2016
Chromatin immunoprecipitation from fixed clinical tissues reveals tumor-specific enhancer profiles
Paloma Cejas, Lewyn Li, Nicholas K O'Neill, et al.
Nature Cell Biology
|
November 5, 2021
FGFR-inhibitor-mediated dismissal of SWI/SNF complexes from YAP-dependent enhancers induces adaptive therapeutic resistance
Yihao Li, Xintao Qiu, Xiaoqing Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 4, 2025
Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer
Betul Ersoy-Fazlioglu, Shreyas Lingadahalli, Umut Berkay Altintas, et al.
Genome Biology
|
October 16, 2020
Clonal tracing reveals diverse patterns of response to immune checkpoint blockade
Shengqing Stan Gu, Xiaoqing Wang, Xihao Hu, et al.
Nature Cell Biology
|
August 17, 2023
KDM6A epigenetically regulates subtype plasticity in small cell lung cancer
Leslie Duplaquet, Yixiang Li, Matthew A Booker, et al.
Oncotarget
|
March 10, 2015
ColoLipidGene: signature of lipid metabolism-related genes to predict prognosis in stage-II colon cancer patients
Teodoro Vargas, Juan Moreno-Rubio, Jesús Herranz, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 21, 2012
Upregulation of trefoil factor 3 (TFF3) after rectal cancer chemoradiotherapy is an adverse prognostic factor and a potential therapeutic target
Enrique Casado, Victor Moreno Garcia, Jose Javier Sánchez, et al.
Cancer Research
|
August 11, 2022
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer
Agostina Nardone, Xintao Qiu, Sandor Spisak, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 90) with videos related to
Sort By:
Page
of 9
Communications Biology
|
February 5, 2025
Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancer
Bengul Gokbayrak, Umut Berkay Altintas, Shreyas Lingadahalli, et al.
Cancer Research
|
September 2, 2020
Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non-Muscle-Invasive Bladder Cancer
Joaquim Bellmunt, Jaegil Kim, Brendan Reardon, et al.
Nature Medicine
|
April 26, 2016
Chromatin immunoprecipitation from fixed clinical tissues reveals tumor-specific enhancer profiles
Paloma Cejas, Lewyn Li, Nicholas K O'Neill, et al.
Nature Cell Biology
|
November 5, 2021
FGFR-inhibitor-mediated dismissal of SWI/SNF complexes from YAP-dependent enhancers induces adaptive therapeutic resistance
Yihao Li, Xintao Qiu, Xiaoqing Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 4, 2025
Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer
Betul Ersoy-Fazlioglu, Shreyas Lingadahalli, Umut Berkay Altintas, et al.
Genome Biology
|
October 16, 2020
Clonal tracing reveals diverse patterns of response to immune checkpoint blockade
Shengqing Stan Gu, Xiaoqing Wang, Xihao Hu, et al.
Nature Cell Biology
|
August 17, 2023
KDM6A epigenetically regulates subtype plasticity in small cell lung cancer
Leslie Duplaquet, Yixiang Li, Matthew A Booker, et al.
Oncotarget
|
March 10, 2015
ColoLipidGene: signature of lipid metabolism-related genes to predict prognosis in stage-II colon cancer patients
Teodoro Vargas, Juan Moreno-Rubio, Jesús Herranz, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 21, 2012
Upregulation of trefoil factor 3 (TFF3) after rectal cancer chemoradiotherapy is an adverse prognostic factor and a potential therapeutic target
Enrique Casado, Victor Moreno Garcia, Jose Javier Sánchez, et al.
Cancer Research
|
August 11, 2022
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer
Agostina Nardone, Xintao Qiu, Sandor Spisak, et al.
Page
of 9